Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 7, Number 5, October 2016, pages 173-177

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension

Figures

Figure 1.
Figure 1. Graphical representation of changes of SBP, DBP and mean BP from baseline after 12 weeks of cilnidipine treatment.
Figure 2.
Figure 2. Graphical representation of changes in heart rate from baseline after 12 weeks of cilnidipine treatment.
Figure 3.
Figure 3. Graphical representation of variation in lipid profile, before and after 12 weeks of treatment.

Tables

Table 1. General Characteristics of Patients of Amlodipine and Cilnidipine Groups
 
N37
Male22
Female15
Age (years)54.17 ± 3.35
Body weight (kg)69.54 ± 7.65
Height (cm)160.55 ± 5.19
BMI27.31 ± 3.7

 

Table 2. Comparison Data (SBP, DBP, mean BP, Heart Rate and Lipid Profile) of Baseline and After 12 Weeks Treatment Along With Corresponding P Values
 
Baseline12th weekP
*Significant.
SBP156.66 ± 5.89132.58 ± 5.970.00*
DBP94.76 ± 3.7778.36 ± 3.660.00*
Mean BP115.47 ± 3.8397.53 ± 2.60.00*
Heart fate75.77 ± 4.2173.47 ± 3.330.00*
Total cholesterol220.51 ± 10.72218.78 ± 9.040.45
Triglyceride172.46 ± 13.42162.46 ± 10.870.00*
LDL145.30 ± 8.78143.97 ± 8.050.49
HDL49.70 ± 5.6749.27 ± 6.550.76